# Harmony TPV Post-Approval Study

> **NCT05077774** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Medtronic Cardiovascular** · enrollment: 150 (estimated)

## Conditions studied

- Congenital Heart Disease
- Tetrology of Fallot
- RVOT Anomaly
- Pulmonary Regurgitation

## Interventions

- **DEVICE:** Harmony TPV System

## Key facts

- **NCT ID:** NCT05077774
- **Lead sponsor:** Medtronic Cardiovascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-10-25
- **Primary completion:** 2026-08
- **Final completion:** 2035-03
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05077774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05077774, "Harmony TPV Post-Approval Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05077774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
